InnovationsKapital

Silecs, Inc. develops and manufactures electronic and optical materials specifically for the microelectronics industry, focusing on applications in semiconductors, image sensors, and displays. The company's materials solutions are designed to integrate seamlessly with standard device manufacturing processes. Their products cater to a variety of needs, including low temperature dielectric applications, CMOS sensors, electro-optic devices, and TFT-LCD displays. Silecs operates research and development, and manufacturing facilities in Espoo, Finland, alongside regional support centers in Asia and the United States. Founded in 2000, Silecs is headquartered in Mountain View, California.

Paxport is a global provider of Merchandising Distribution Systems (MDS), specializing in the integration of merchandising expertise with content distribution and packaging technology. Following its acquisition of Multicom in 2016, Paxport has established itself as a leader in delivering comprehensive travel solutions. The company has built a strong reputation in the Nordics and Benelux regions over the past two decades. Paxport operates its technology center in Bristol, UK, while maintaining its merchandising center in Stockholm, Sweden, ensuring a robust infrastructure to support its extensive service offerings.

Oxeon is a privately owned company that holds several patents for processes and materials.

Action Pharma A/S is a biotechnology company focused on research and development, specializing in the discovery and development of novel drugs for cardiovascular, inflammatory, and metabolic diseases. Founded in 2000 and based in Holte, Denmark, the company aims to create treatment options for conditions such as type-II diabetes, obesity, kidney injury related to cardiac surgery, inflammatory bowel disease, rheumatoid arthritis, and inflammatory skin diseases like atopic dermatitis. Its product pipeline includes AP214, a modified MSH peptide analogue for post-surgical kidney injury; AP1030 and AP11 series, oral medications for type-II diabetes; AP1189, an anti-inflammatory compound for various inflammatory diseases; and AP405, another modified MSH peptide aimed at treating inflammatory skin conditions. Action Pharma's approach focuses on targeting melanocortin receptors, progressing its candidates toward clinical proof of concept to facilitate future partnerships.

SantoSolve is focused on developing topical analgesic products that utilize non-radioactive strontium as the active ingredient. The company aims to provide effective pain management solutions that mitigate the adverse effects and health risks associated with traditional pain medications. Their lead product, 2PX, is designed for topical application and employs dermal penetration enhancers to deliver the active agent to targeted areas beneath the skin. Clinical trials have demonstrated that 2PX exhibits strong analgesic effects for various pain conditions, including nociceptive and neuropathic pain, with minimal systemic absorption and few minor adverse effects. The product has successfully completed Phase II clinical trials, particularly in osteoarthritis, where its analgesic efficacy was shown to be significantly superior to placebo treatments. SantoSolve's innovative approach offers patients a promising alternative for managing local and neuropathic pain conditions.

Medius is a global leader in cloud-based accounts payable (AP) invoice automation solutions. It streamlines the entire purchase-to-pay process by automating invoice processing, reducing manual work, accelerating lead times, enhancing financial control, and improving visibility of key metrics for its clients worldwide.

Projectplace International develops collaborative tools aimed at enhancing project management and teamwork for individuals and organizations. The company offers a range of solutions, from a free ToDo collaboration tool to a comprehensive project management platform. Their web-based tool supports project planning, execution, and delivery, catering to geographically dispersed and cross-organizational teams. By providing secure and scalable collaboration resources, Projectplace enables businesses to improve communication and efficiency in their projects.

Hexaformer specializes in the manufacturing of closed symmetrical delta-shaped transformer cores, providing transformer and reactor solutions aimed at enhancing energy distribution. The company's innovative technology results in products that exhibit lower losses, reduced weight, and minimized material usage, contributing to more efficient power transmission. These "green" features have attracted significant interest from various industries. Founded in 2004 and based in Västervik, Sweden, Hexaformer also licenses its technology to manufacturers worldwide. The company is backed by a mix of prominent venture capital firms and private investors, reinforcing its position in the energy sector.

Jasper Design Automation, Inc. is an electronic design automation company based in Mountain View, California, specializing in semiconductor design, verification, and reuse. Founded in 1999 as Tempus Fugit, Inc., it rebranded in 2003 to its current name. The company offers a range of products, including the JasperGold verification system, which provides solutions for bug detection and debugging, and the GamePlan verification planner. In addition to its software offerings, Jasper provides verification products, integrated circuit design blocks, and comprehensive customer support, including methodology consulting, training, and turnkey proof kit development. The company also delivers on-site consulting services to facilitate the deployment of structured verification methodologies, assists in writing formal test plans for specific designs, and offers turnkey verification services. Through its technology, including ActiveProp, a property synthesis tool, Jasper aims to enhance the adoption of assertion-based verification and simulation, ultimately enabling clients to achieve high value and return on investment in their electronic systems and semiconductor projects.

Silecs, Inc. develops and manufactures electronic and optical materials specifically for the microelectronics industry, focusing on applications in semiconductors, image sensors, and displays. The company's materials solutions are designed to integrate seamlessly with standard device manufacturing processes. Their products cater to a variety of needs, including low temperature dielectric applications, CMOS sensors, electro-optic devices, and TFT-LCD displays. Silecs operates research and development, and manufacturing facilities in Espoo, Finland, alongside regional support centers in Asia and the United States. Founded in 2000, Silecs is headquartered in Mountain View, California.

Isconova AB is an R&D company that develops and commercializes adjuvants and vaccines. It provides adjuvants for veterinary and human vaccines for an enhanced immune reaction with a longer duration. The products of the company include Matrix-M, which is a cell-mediated and antibody-mediated immune response for use in vaccines for humans, dogs, and cats. Matrix-C vaccines are used for horses, and Matrix-Q vaccines are used for cows and fish. Matrix-F is also used for fish. It also offers AbISCO research reagents, including AbISCO-100, for use in saponin-sensitive animal species, such as mice.

Novavax Inc., established in 1987 and headquartered in Gaithersburg, Maryland, is a late-stage biotechnology company dedicated to discovering, developing, and commercializing vaccines to prevent serious infectious diseases worldwide. Its primary focus lies in advancing vaccine candidates through clinical trials, with notable projects including ResVax for RSV in infants via maternal immunization (Phase III), NanoFlu for seasonal influenza in older adults (Phase III), and NVX-CoV2373 for COVID-19 (preclinical). Novavax's proprietary Matrix-M adjuvant enhances immune response and enables lower antigen doses. The company collaborates globally to address urgent health needs, with Europe being its primary revenue source.

Syntensia is a Stockholm-based company that specializes in providing on-demand network security solutions through a subscription model. Founded in 2005, Syntensia targets small and medium-sized businesses in high-growth emerging markets, offering comprehensive security services tailored to meet their needs. The company aims to deliver effective and accessible network protection, ensuring that its clients can operate securely in an increasingly digital landscape.

Enigma Semiconductor develops advanced silicon solutions aimed at enhancing wired communications. The company focuses on creating innovative components and subsystems for various applications, including metropolitan and access networks, enterprise and internet infrastructure, and storage systems. Enigma offers semiconductors for switching systems, line card, and backplane systems, supporting link speeds of up to 6.25G and line card speeds of up to 1x40G. The management team comprises experienced professionals with backgrounds in prominent technology firms, ensuring a strong foundation for the company's growth and innovation in the semiconductor industry.

SantoSolve is focused on developing topical analgesic products that utilize non-radioactive strontium as the active ingredient. The company aims to provide effective pain management solutions that mitigate the adverse effects and health risks associated with traditional pain medications. Their lead product, 2PX, is designed for topical application and employs dermal penetration enhancers to deliver the active agent to targeted areas beneath the skin. Clinical trials have demonstrated that 2PX exhibits strong analgesic effects for various pain conditions, including nociceptive and neuropathic pain, with minimal systemic absorption and few minor adverse effects. The product has successfully completed Phase II clinical trials, particularly in osteoarthritis, where its analgesic efficacy was shown to be significantly superior to placebo treatments. SantoSolve's innovative approach offers patients a promising alternative for managing local and neuropathic pain conditions.

Apptus is a developer of online merchandising software designed to enhance eCommerce platforms through advanced search systems. By leveraging big data and predictive analytics, the company provides personalized product assortments and marketing campaigns, which aim to improve customer experiences. Its software delivers a unified service that integrates search, navigation, recommendations, and content, constantly optimizing strategies to align product exposure with broader conversion, revenue, and profit objectives. This approach enables retailers to enhance sales performance, reduce costs, and drive organizational efficiency.

Syntune is a developer of tunable lasers, primarily serving the telecommunications sector. The company's innovative laser technology significantly reduces costs for wavelength division multiplexing (WDM) systems, which are essential for modern fiber optic networks. Syntune's lasers are designed for various applications, including fiber-optic communications and sensor systems, making them versatile within the industry. The company was acquired by Ignis ASA, further enhancing its capabilities and market reach.

Hymite is a venture funded product company bringing to market the next generation packaging platform for use with High Power (HP) / Ultra-high Brightness (UHB) LEDs. Hymite's Engineered Silicon (Si) package platform delivers new levels of performance and value to their customers developing products for Solid State Lighting applications.

BONESUPPORT AB is a medical technology company based in Lund, Sweden, specializing in the development of injectable bioceramic bone graft substitutes aimed at treating fractures and bone voids resulting from trauma, infection, disease, or surgery. Founded in 1999, the company offers a range of products, including CERAMENT BONE VOID FILLER, CERAMENT G, and CERAMENT V. These products are designed to address various medical conditions such as chronic osteomyelitis and infected diabetic foot ulcers. CERAMENT G and CERAMENT V are antibiotic-eluting bone graft substitutes that enhance bone healing, utilizing gentamicin and vancomycin, respectively. BONESUPPORT operates additional locations in Frankfurt, Zurich, London, Boston, and Haryana, India, and is committed to improving the quality of life for patients with bone disorders through innovative biomaterial solutions.

Action Pharma A/S is a biotechnology company focused on research and development, specializing in the discovery and development of novel drugs for cardiovascular, inflammatory, and metabolic diseases. Founded in 2000 and based in Holte, Denmark, the company aims to create treatment options for conditions such as type-II diabetes, obesity, kidney injury related to cardiac surgery, inflammatory bowel disease, rheumatoid arthritis, and inflammatory skin diseases like atopic dermatitis. Its product pipeline includes AP214, a modified MSH peptide analogue for post-surgical kidney injury; AP1030 and AP11 series, oral medications for type-II diabetes; AP1189, an anti-inflammatory compound for various inflammatory diseases; and AP405, another modified MSH peptide aimed at treating inflammatory skin conditions. Action Pharma's approach focuses on targeting melanocortin receptors, progressing its candidates toward clinical proof of concept to facilitate future partnerships.

Resistentia Pharmaceuticals, a biopharmaceutical company, develops immunotherapeutic products for allergic asthma and inflammatory disorders. It provides Immunoglobulin E for allergic reactions, including asthma, rhinitis, and dermatitis; and C5a for the treatment of inflammatory conditions, such as rheumatoid arthritis, asthma, and multiple sclerosis. Resistentia Pharmaceuticals AB was founded in 1998 and is based in Uppsala, Sweden.

Ludesi is a rapidly growing bioinformatics company and the first company to offer image analysis of 2D electrophoresis gels as a globally accessible service. Their customers include some of the most prominent research institutes, pharmaceutical and biotech companies worldwide.

21 Grams specializes in postal management services for corporate clients, utilizing advanced technology to optimize postage. The company combines its expertise in postal operations with knowledge of print and document management software to deliver effective solutions. By outsourcing bulk mailing production, clients can streamline their communication processes and substantially lower postage costs by taking advantage of savings in deregulated postage markets.

BONESUPPORT AB is a medical technology company based in Lund, Sweden, specializing in the development of injectable bioceramic bone graft substitutes aimed at treating fractures and bone voids resulting from trauma, infection, disease, or surgery. Founded in 1999, the company offers a range of products, including CERAMENT BONE VOID FILLER, CERAMENT G, and CERAMENT V. These products are designed to address various medical conditions such as chronic osteomyelitis and infected diabetic foot ulcers. CERAMENT G and CERAMENT V are antibiotic-eluting bone graft substitutes that enhance bone healing, utilizing gentamicin and vancomycin, respectively. BONESUPPORT operates additional locations in Frankfurt, Zurich, London, Boston, and Haryana, India, and is committed to improving the quality of life for patients with bone disorders through innovative biomaterial solutions.

Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.

Cellartis AB is a Swedish/British biotechnology company focused on pluripotent stem cells and technology for drug discovery research, toxicity testing and regenerative medicine Since 2001, Cellartis has worked globally with industry and academia, platform providers and end users to develop the next generation of advanced stem cell products and technologies. The company leverages a deep experience in stem cell handling, scale up and differentiation into mature and functional human cells. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools today.

Dolthera GmbH is a biopharmaceutical company that is developing an innovative class of nucleic-acid-based anti-inflammatory drugs. These drugs, based on oligonucleotides that act as decoys for disease-related transcription factors are all directed against biologically validated targets in major chronic diseases with high unmet medical need. With this business concept and the underlying patent-protected technologies, AVONTEC won in 2003 the prestigious German Founders Award that is backed by McKinsey & Company. Initially, the Company has chosen to focus its patented technology on chronic inflammatory respiratory system and skin diseases. AVONTEC currently has five programs in respiratory disease, skin disease, transplant rejection, cardiovascular disease and autoimmune disease under development. All these indications represent areas with high unmet medical need and strong commercial potential.

NordNav Technologies is a Stockholm-based company specializing in the development of software GPS receivers tailored for the mobile and automotive sectors. The firm focuses on creating innovative global navigation satellite system receivers, positioning itself as a key player in enhancing navigation technology for various applications. By leveraging advanced software solutions, NordNav aims to meet the growing demand for accurate and reliable positioning systems in today's mobile-driven world.

As of December 11, 2008 Taktio ApS went out of business. Taktio ApS develops and supplies man machine interfaces internationally. The company offers technology for high resolution and touch screen applications. Its products are used in mobile handset displays, computer monitors, windows, and glass walls. Taktio ApS was formerly known as O-pen ApS. The company was founded in 2003 and is based in Copenhagen, Denmark.

Syntune is a developer of tunable lasers, primarily serving the telecommunications sector. The company's innovative laser technology significantly reduces costs for wavelength division multiplexing (WDM) systems, which are essential for modern fiber optic networks. Syntune's lasers are designed for various applications, including fiber-optic communications and sensor systems, making them versatile within the industry. The company was acquired by Ignis ASA, further enhancing its capabilities and market reach.

Silecs, Inc. develops and manufactures electronic and optical materials specifically for the microelectronics industry, focusing on applications in semiconductors, image sensors, and displays. The company's materials solutions are designed to integrate seamlessly with standard device manufacturing processes. Their products cater to a variety of needs, including low temperature dielectric applications, CMOS sensors, electro-optic devices, and TFT-LCD displays. Silecs operates research and development, and manufacturing facilities in Espoo, Finland, alongside regional support centers in Asia and the United States. Founded in 2000, Silecs is headquartered in Mountain View, California.

Enigma Semiconductor develops advanced silicon solutions aimed at enhancing wired communications. The company focuses on creating innovative components and subsystems for various applications, including metropolitan and access networks, enterprise and internet infrastructure, and storage systems. Enigma offers semiconductors for switching systems, line card, and backplane systems, supporting link speeds of up to 6.25G and line card speeds of up to 1x40G. The management team comprises experienced professionals with backgrounds in prominent technology firms, ensuring a strong foundation for the company's growth and innovation in the semiconductor industry.

Hymite is a venture funded product company bringing to market the next generation packaging platform for use with High Power (HP) / Ultra-high Brightness (UHB) LEDs. Hymite's Engineered Silicon (Si) package platform delivers new levels of performance and value to their customers developing products for Solid State Lighting applications.

Appium is one of the leading vendors of next generation telecommunication application platforms and applications for the converging IT and Telecom market. To enable its business Appium delivers the leading telecom application platform and service creation environment for the OSA/Parlay market (www.parlay.org). Appium complements its service creation and deployment platforms offering with a range of commercially available applications and application components together with deployment and business models for addressing the enterprise as well as consumer market segments. Appium works in a standard Independent Software Vendor (ISV) business model. Appium addresses its offerings to Network Operators, Service Providers, Application Developers and, as the market evolves, Enterprises. Appium was founded in 1992, with head offices in Malmoe, Sweden, and originally provided professional services and solutions in the areas of Intelligent Networks, Mobile Systems, NGN and services. In 2000, the company decided to exploit the opportunities arising from the OSA/Parlay standards and was re-oriented to be a product company.

Proximion specializes in fiber optic technology, particularly utilizing Fiber Bragg Grating (FBG) to enhance network reliability and performance. Its flagship product, WISTOM, integrates both optical channel monitoring and optical performance monitoring, allowing for comprehensive analysis of individual wavelength channels. This capability enables the identification and resolution of network issues, ultimately ensuring Quality of Service (QoS) for operators. Proximion's offerings extend beyond telecommunications, serving heavy industry and aerospace sectors as well. The company provides a range of products, including optical modules, dispersion compensation modules, and fiber optic sensor systems, aimed at mitigating network faults and reducing downtime costs for its clients.

Gyros is the world leader in automated micro-immunoassays for therapeutic protein development. Gyrolab, the company's automated and open platform, is a versatile analytical tool that dramatically reduces the time required to optimize and execute immunoassays. Time for assay optimization is often cut from weeks, to a matter of days. This results in increased efficiency in process development and in clinical evaluation of therapeutic proteins. The ease of assay transfer is unsurpassed in the industry.

Proximion specializes in fiber optic technology, particularly utilizing Fiber Bragg Grating (FBG) to enhance network reliability and performance. Its flagship product, WISTOM, integrates both optical channel monitoring and optical performance monitoring, allowing for comprehensive analysis of individual wavelength channels. This capability enables the identification and resolution of network issues, ultimately ensuring Quality of Service (QoS) for operators. Proximion's offerings extend beyond telecommunications, serving heavy industry and aerospace sectors as well. The company provides a range of products, including optical modules, dispersion compensation modules, and fiber optic sensor systems, aimed at mitigating network faults and reducing downtime costs for its clients.

A vertical B2B portal for the printing industry.

Spotfire, a product of TIBCO Software, specializes in interactive visual data analytics applications and services. It empowers users by providing a platform for real-time data analysis, enabling them to identify trends, patterns, and relationships within their data. By focusing on a visual approach, Spotfire helps executives, developers, and business users make informed decisions swiftly. Over the years, numerous organizations have integrated Spotfire into their operations to enhance their data-driven strategies and improve overall performance. Through its solutions, Spotfire transforms complex data into actionable insights, facilitating smarter business actions and more effective decision-making.

Spotfire, a product of TIBCO Software, specializes in interactive visual data analytics applications and services. It empowers users by providing a platform for real-time data analysis, enabling them to identify trends, patterns, and relationships within their data. By focusing on a visual approach, Spotfire helps executives, developers, and business users make informed decisions swiftly. Over the years, numerous organizations have integrated Spotfire into their operations to enhance their data-driven strategies and improve overall performance. Through its solutions, Spotfire transforms complex data into actionable insights, facilitating smarter business actions and more effective decision-making.